Literature DB >> 6117495

Characterisation of the abnormal pancreatic D and A cell function in streptozotocin diabetic dogs: studies with D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-glucose, and L-arginine.

K Hermansen.   

Abstract

Pancreatic D and A cell function is deranged in streptozotocin diabetes. To investigate this, the effect of D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose and glucose variations during arginine stimulation on the release of somatostatin and glucagon from the isolated pancreas of normal and streptozotocin diabetic dogs was studied. Concentrations of the trioses, D-glyceraldehyde (1.25 and 2.5 mmol/l) and dihydroxyacetone (11 mmol/l), which normally stimulate D cells, did not influence the release of somatostatin in the diabetic dog. However, the higher concentration of D-glyceraldehyde (5 mmol/l) and dihydroxyacetone (11 mmol/l), which normally stimulate D cells, did not influence the release of somatostatin in the diabetic dog. However, the higher concentration of D-glyceraldehyde (5 mmol/l) suppressed D cell ssecretion in the diabetic animals at 0 and 8.3 mmol/l glucose. A cell secretion was significantly suppressed at the higher glucose level in response to both 2.5 and 5 mmol/l of te triose. This inhibition may be explained by a non-specific effect induced by the high dose of this triose. The addition of 5 mmol/l mannoheptulose, which normally reduces glucose-induced somatostatin secretion and stimulates glucagon release, did not affect hormone secretion. In both the diabetic and the normal animals, arginine (5 mmol/l) stimulated somatostatin and glucagon secretion. Although arginine was able to stimulate D and A cell secretion in the diabetic dogs, it was however unable to restore the response to changes in glucose concentration between 1.4 and 8.3 mmol/l to normal. These results demonstrate that the abnormal pancreatic D and A cell function in streptozotocin diabetes is characterised by an impaired response to glucose and certain glucose metabolites and probably results from a specific defect in glucose recognition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117495     DOI: 10.1007/bf00257791

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

Review 1.  Intermediary metabolism and insulin secretion from isolated rat islets of Langerhans.

Authors:  W S Zawalich
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

2.  Increased somatostatin release from pancreases of alloxan diabetic rats perfused in vitro.

Authors:  M Hara; G Patton; J Gerich
Journal:  Life Sci       Date:  1979-02-12       Impact factor: 5.037

3.  Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone.

Authors:  H Orskov; H G Thomsen; H Yde
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

Review 4.  Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

5.  Glucose and glucagon stimulate the secretion of somatostatin from the perfused canine pancreas.

Authors:  G C Weir; E Samols; J A Day; Y C Patel
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

6.  Notes on the glucose oxidase method.

Authors:  N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

7.  Pancreatic D-cell recognition of D-glucose: studies with D-glucose, D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-fructose, D-galactose, and D-ribose.

Authors:  K Hermansen
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

8.  Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine.

Authors:  K Hermansen; S E Christensen; H Orskov
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

9.  Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells.

Authors:  K Hermansen; H Orskov; S E Christensen
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

10.  The role of sodium in somatostatin secretion: evidence for the involvement of Na+ channels in the release mechanism.

Authors:  K Hermansen
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

View more
  5 in total

1.  Effects of whey proteins on glucose metabolism in normal Wistar rats and Zucker diabetic fatty (ZDF) rats.

Authors:  Søren Gregersen; Sara Bystrup; Ann Overgaard; Per B Jeppesen; Anne C Sønderstgaard Thorup; Erik Jensen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2014-02-10

2.  Stimulation of somatostatin secretion by 3-O-methylglucose in the perfused dog pancreas.

Authors:  K Hermansen; S Lindskog; B Ahrén
Journal:  Int J Pancreatol       Date:  1996-10

3.  The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after eight weeks treatment in the Goto-Kakizaki rat.

Authors:  Stig E U Dyrskog; Per B Jeppesen; Jianguo Chen; Lars P Christensen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2005-08-10

4.  Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat.

Authors:  Per B Jeppesen; Stig E Dyrskog; Andreas Agger; Soren Gregersen; Michele Colombo; Jianzhong Xiao; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2007-02-10

5.  Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.

Authors:  G J Taborsky; J W Ensinck
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.